Piet Wigerinck

2.5k total citations
44 papers, 1.8k citations indexed

About

Piet Wigerinck is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Piet Wigerinck has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 16 papers in Organic Chemistry and 13 papers in Molecular Biology. Recurrent topics in Piet Wigerinck's work include HIV/AIDS drug development and treatment (19 papers), Synthesis and Characterization of Heterocyclic Compounds (12 papers) and HIV Research and Treatment (10 papers). Piet Wigerinck is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), Synthesis and Characterization of Heterocyclic Compounds (12 papers) and HIV Research and Treatment (10 papers). Piet Wigerinck collaborates with scholars based in Belgium, United States and Sweden. Piet Wigerinck's co-authors include Marie‐Pierre de Béthune, Dominique Surleraux, Piet Herdewijn, Rudi Pauwels, Sandra De Meyer, Hilde Azijn, Abdellah Tahri, Nancy M. P. King, Celia A. Schiffer and M. Prabu-Jeyabalan and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Virology.

In The Last Decade

Piet Wigerinck

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piet Wigerinck Belgium 19 1.1k 768 439 438 421 44 1.8k
Joseph A. Martin United Kingdom 21 1.0k 1.0× 635 0.8× 582 1.3× 784 1.8× 388 0.9× 42 2.1k
Sudthida Vasavanonda United States 16 1.5k 1.4× 1.3k 1.6× 481 1.1× 488 1.1× 217 0.5× 27 2.1k
Neil R. Hartman United States 19 1.1k 1.0× 917 1.2× 163 0.4× 503 1.1× 454 1.1× 41 1.9k
John H. Merrett United Kingdom 8 684 0.6× 499 0.6× 293 0.7× 429 1.0× 252 0.6× 10 1.2k
George A. Freeman United States 16 1.1k 1.0× 809 1.1× 549 1.3× 645 1.5× 409 1.0× 26 2.0k
Blanda Stammen United Kingdom 12 505 0.5× 653 0.9× 273 0.6× 420 1.0× 195 0.5× 15 1.4k
J P Sommadossi United States 21 1.1k 1.0× 621 0.8× 326 0.7× 774 1.8× 666 1.6× 49 2.0k
Yasuhiro Koh United States 27 1.7k 1.5× 1.6k 2.1× 562 1.3× 787 1.8× 383 0.9× 40 2.4k
Lotta Vrang Sweden 26 1.2k 1.1× 795 1.0× 667 1.5× 709 1.6× 540 1.3× 78 2.3k
Masayuki Amano Japan 24 946 0.9× 736 1.0× 465 1.1× 313 0.7× 274 0.7× 72 1.5k

Countries citing papers authored by Piet Wigerinck

Since Specialization
Citations

This map shows the geographic impact of Piet Wigerinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piet Wigerinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piet Wigerinck more than expected).

Fields of papers citing papers by Piet Wigerinck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piet Wigerinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piet Wigerinck. The network helps show where Piet Wigerinck may publish in the future.

Co-authorship network of co-authors of Piet Wigerinck

This figure shows the co-authorship network connecting the top 25 collaborators of Piet Wigerinck. A scholar is included among the top collaborators of Piet Wigerinck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piet Wigerinck. Piet Wigerinck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durez, Patrick, et al.. (2020). Treatment innovation for patients: a collaborative network in the Benelux and an inside view of 20 years of Galapagos. Acta Clinica Belgica. 77(1). 233–240. 4 indexed citations
2.
Westhovens, René, Filip De Keyser, Е. Л. Насонов, et al.. (2012). Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial. Annals of the Rheumatic Diseases. 72(5). 741–744. 18 indexed citations
3.
4.
Westhovens, René, Filip De Keyser, Е. Л. Насонов, et al.. (2011). A twelve-week exploratory phase II trial of GLPG0259 versus placebo in patients with active rheumatoid arthritis and inadequate response to methotrexate. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
5.
6.
Lorenzon, Giocondo, Lien Gheyle, Eva Vets, et al.. (2010). Abstract 1568: GLPG0187, a small molecule integrin antagonist, shows good safety and decrease in CTX levels in single ascending dose study. Cancer Research. 70(8_Supplement). 1568–1568. 3 indexed citations
7.
Baert, Lieven, Gerben van ‘t Klooster, Koen Iterbeke, et al.. (2009). Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment. European Journal of Pharmaceutics and Biopharmaceutics. 72(3). 502–508. 185 indexed citations
8.
Lin, Tse‐I, Oliver Lenz, Gregory Fanning, et al.. (2009). In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor. Antimicrobial Agents and Chemotherapy. 53(4). 1377–1385. 142 indexed citations
9.
Raboisson, Pierre, Tse‐I Lin, Herman de Kock, et al.. (2008). Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5095–5100. 18 indexed citations
10.
Gyseghem, Elke Van, Lieven Baert, Jan Rosier, et al.. (2008). Powder for reconstitution of the anti-HIV-1 drug TMC278 – Formulation development, stability and animal studies. European Journal of Pharmaceutics and Biopharmaceutics. 70(3). 853–860. 15 indexed citations
11.
Schueller, Laurent, Lieven Baert, Sophie Lachau‐Durand, et al.. (2007). Dog model with implanted pump to test boosters for antiretroviral medication. International Journal of Pharmaceutics. 355(1-2). 45–52. 2 indexed citations
12.
Jochmans, Dirk, Jérôme Deval, Bart Kesteleyn, et al.. (2006). Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action. Journal of Virology. 80(24). 12283–12292. 77 indexed citations
13.
Surleraux, Dominique, Geert Pille, Louis Maes, et al.. (2005). Design of HIV-1 Protease Inhibitors Active on Multidrug-Resistant Virus. Journal of Medicinal Chemistry. 48(6). 1965–1973. 59 indexed citations
14.
Olivier, A., G. Evrard, Arthur Van Aerschot, et al.. (1996). Relationship between structural properties and affinity for herpes simplex virus type 1 thymidine kinase of bromine substituted 5-heteroaromatic 2′-deoxyuridines. Antiviral Research. 30(2-3). 63–74. 5 indexed citations
15.
Olivier, Anne, Christine Evrard, G. Evrard, et al.. (1994). Stereoelectronic properties of five anti-HSV-1 2′-deoxynucleosides analogues with heterocyclic substituents in the 5-position: A comparison with BVDU. Antiviral Research. 24(4). 289–304. 8 indexed citations
16.
Wigerinck, Piet, et al.. (1993). Synthesis and antiviral activity of 5-thien-2-yl-2'-deoxyuridine analogs. Journal of Medicinal Chemistry. 36(5). 538–543. 55 indexed citations
17.
Pannecouque, Christophe, Piet Wigerinck, Arthur Van Aerschot, & Piet Herdewijn. (1992). Dimeric building blocks with N-cyanoguanidine linkage for oligonucleotide synthesis. Tetrahedron Letters. 33(49). 7609–7612. 13 indexed citations
18.
Wigerinck, Piet, Robert Snoeck, P. Claes, Erik De Clercq, & Piet Herdewijn. (1991). Synthesis and antiviral activity of 5-heteroaryl-substituted 2'-deoxyuridines. Journal of Medicinal Chemistry. 34(6). 1767–1772. 41 indexed citations
19.
Herdewijn, Piet, et al.. (1991). Synthesis of 8‐Mercapto‐2′,3′‐Dideoxyadenosine and 8‐Mercapto‐2′,3′‐Dideoxyinosine. Bulletin des Sociétés Chimiques Belges. 100(2). 183–184. 2 indexed citations
20.
Wigerinck, Piet, Arthur Van Aerschot, G. Janssen, et al.. (1990). Synthesis and antiviral activity of 3'-heterocyclic substituted 3'-deoxythymidines. Journal of Medicinal Chemistry. 33(2). 868–873. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph A. Martin Breakdown of academic impact, for papers by Sudthida Vasavanonda Breakdown of academic impact, for papers by Neil R. Hartman Breakdown of academic impact, for papers by John H. Merrett Breakdown of academic impact, for papers by George A. Freeman Breakdown of academic impact, for papers by Blanda Stammen Breakdown of academic impact, for papers by J P Sommadossi Breakdown of academic impact, for papers by Yasuhiro Koh Breakdown of academic impact, for papers by Lotta Vrang Breakdown of academic impact, for papers by Masayuki Amano
Rankless by CCL
2026